University of Maryland, Greenebaum Comprehensive Cancer Center. — Baltimore, Maryland

University of Maryland, Greenebaum Comprehensive Cancer Center. is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Maryland, Greenebaum Comprehensive Cancer Center. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland, Greenebaum Comprehensive Cancer Center.?

University of Maryland, Greenebaum Comprehensive Cancer Center. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland, Greenebaum Comprehensive Cancer Center. conducted?

University of Maryland, Greenebaum Comprehensive Cancer Center. has 1 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer.

Is University of Maryland, Greenebaum Comprehensive Cancer Center. accredited by Crixeo Health?

University of Maryland, Greenebaum Comprehensive Cancer Center. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Maryland, Greenebaum Comprehensive Cancer Center.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.